Regencell Bioscience Holdings Limited (RGC)
NASDAQ
Closed
Oct 23, 2026
Day's Range
7.5552 wk Range
4.51Overview - RGC - Regencell Bioscience Holdings Limited
Key Statistics
Valuation
Enterprise Value
4.96B
P/E (Trailing)
-1,433.33
Price / Book
377.77
EV / EBITDA
-426.82
Profitability
Profit Margin
0.00%
Operating Margin
0.00%
Return on Assets
-71.54%
Return on Equity
-128.52%
Ownership
Shares Outstanding
494.48M
Float
55.61M
Short % of Shares Outstanding
1.16%
Held by Insiders
88.42%
Held by Institutions
0.28%
Price stats
Beta
1.16
50-Day Avg
6.31
200-Day Avg
18.44
Analyst Consensus
15 analysts
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - RGC - Regencell Bioscience Holdings Limited
Peers - RGC - Regencell Bioscience Holdings Limited
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on NASDAQ.
- RGCNASDAQRegencell Bioscience Holdings Limited5.18BMarket Cap-50.72%52-week change-1433.33P/E (Trailing)0.00%Profit Margin
- NBIXNASDAQNeurocrine Biosciences, Inc.13.92BMarket Cap-4.14%52-week change19.90P/E (Trailing)20.91%Profit Margin
- ALKSNASDAQAlkermes plc6.91BMarket Cap+24.84%52-week change108.47P/E (Trailing)3.96%Profit Margin
- AMRXNASDAQAmneal Pharmaceuticals, Inc.6.74BMarket Cap+47.11%52-week change39.14P/E (Trailing)5.04%Profit Margin
- LNTHNASDAQLantheus Holdings Inc.6.52BMarket Cap+42.25%52-week change24.14P/E (Trailing)17.69%Profit Margin
- KNSANASDAQKiniksa Pharmaceuticals Ltd6.21BMarket Cap+49.26%52-week change81.61P/E (Trailing)9.59%Profit Margin
- INDVNASDAQIndivior Pharmaceuticals, Inc.4.06BMarket Cap+28.11%52-week change12.36P/E (Trailing)26.74%Profit Margin
Profile Summary - RGC - Regencell Bioscience Holdings Limited
About
Regencell Bioscience Holdings Limited is an early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine-based products. Regencell Bioscience Holdings Limited concentrates on treatments for neurocognitive disorders and degeneration, with particular…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
